Yonsei University
Clinical trials sponsored by Yonsei University, explained in plain language.
-
New heart stent designed to dissolve, aiming to reduce Long-Term risks
Disease control CompletedThis study observed how well a new type of heart stent works in everyday patients. The Ultimaster stent is coated with a medicine and a polymer that dissolves over 3-4 months, which may reduce long-term inflammation and clotting risks compared to older stents. Researchers followe…
Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New wrist technique aims to make heart procedures safer and faster
Disease control CompletedThis study tested a new way to perform a common heart artery procedure (PCI) by accessing the artery through a spot on the wrist instead of the groin. It used a specially designed thinner tube to see if this approach is safe and effective, particularly for reducing bleeding and o…
Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Heart attack prevention: is lower cholesterol always better?
Disease control CompletedThis study tested whether aiming for very low 'bad' cholesterol (LDL) levels is better than standard low levels for people with heart disease. Over 3,000 participants were randomly assigned to either a very low target or a standard target, using either a single cholesterol drug o…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug trial aims to shield stomachs from steroid side effects
Disease control CompletedThis study tested whether a medication called fexuprazan could prevent or control gastritis (stomach lining irritation) in adults needing long-term steroid treatment for respiratory diseases. It compared fexuprazan against an existing stomach-protecting drug (lansoprazole) over f…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New heart stent tested on most vulnerable patients
Disease control CompletedThis study observed 200 patients with complex coronary artery disease who received a specific type of drug-coated stent. The goal was to see how safe and effective this stent is over the long term in patients at high risk for heart attacks or other heart-related problems. Researc…
Sponsor: Yonsei University • Aim: Disease control
Last updated Mar 17, 2026 13:01 UTC
-
Heart monitor showdown: 1 day vs. 8 days - which finds more dangerous irregular heartbeats?
Diagnosis CompletedThis study tested whether wearing a heart monitor for 8 days finds more cases of atrial fibrillation (a dangerous irregular heartbeat) than wearing it for just 1 day. It involved 1,000 adults aged 75+ or at high risk for stroke who had symptoms like palpitations or dizziness. Res…
Phase: NA • Sponsor: Yonsei University • Aim: Diagnosis
Last updated Mar 19, 2026 14:56 UTC
-
One-Time treatment tested for tighter, more defined jawlines
Symptom relief CompletedThis study tested whether a single session of a radiofrequency skin treatment could improve jawline definition and facial contouring. Researchers followed 22 women aged 38-50 for 8 weeks after their treatment. They measured changes in jawline position and facial volume using 3D i…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Apr 01, 2026 21:41 UTC
-
At-Home brain zapping tested as new hope for depression
Symptom relief CompletedThis study tested whether a non-invasive brain stimulation device, used at home, could help reduce symptoms of depression. Nearly 200 adults with mild to moderate depression used the device on themselves for six weeks. Researchers measured changes in depression, anxiety, and thin…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Apr 01, 2026 14:43 UTC
-
Face-Off: new skin booster challenges standard treatment in wrinkle study
Symptom relief CompletedThis study tested whether a new skin booster made from processed human tissue, when mixed with a standard hyaluronic acid filler, works better than the standard filler alone. Researchers compared the two treatments by injecting one into each cheek of 20 participants over three mo…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Breathing aid tested for overweight patients in lung cancer surgery
Symptom relief CompletedThis study tested whether a drug called iloprost, given as an inhaled mist, could help maintain better oxygen levels in the blood of obese patients during a specific type of lung surgery. During this surgery, called one-lung ventilation, patients breathe with only one lung, which…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC
-
Study tests safer wrist approach to shield heart doctors from radiation
Knowledge-focused CompletedThis study aimed to see if a new approach to accessing heart arteries through the left wrist exposes doctors to less radiation than the standard right wrist approach. Over 1,000 patients scheduled for heart imaging or stenting were randomly assigned to one of the two methods. Res…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Scientists hunt for clues to personalize lung cancer treatment
Knowledge-focused CompletedThis study aimed to find biological markers in the blood and tumors of lung cancer patients that could predict who would benefit from the immunotherapy drug atezolizumab. It involved 100 patients with advanced non-small cell lung cancer whose disease had progressed after prior tr…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Could a natural hormone speed up blood recovery after heart surgery?
Knowledge-focused CompletedThis study aimed to understand if a hormone called erythroferron helps patients recover from low blood counts (anemia) after heart valve surgery. Researchers measured this hormone and blood levels in 150 patients having elective surgery. The goal was to see if higher hormone leve…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC
-
Could a common vitamin help heart surgery patients bounce back faster?
Knowledge-focused CompletedThis study looked at whether a patient's vitamin D level before heart bypass surgery is linked to how well their blood recovers afterward. Researchers followed 135 patients to see if vitamin D influences hormones that control iron and red blood cell production. The goal was to ga…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC